Cellular therapies for treating pain associated with spinal cord injury

about

Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results.Collagen-Binding Hepatocyte Growth Factor (HGF) alone or with a Gelatin- furfurylamine Hydrogel Enhances Functional Recovery in Mice after Spinal Cord Injury.

P2860

Q35091885-BC8818D6-B018-4818-9485-AFAD17CEFBD5 Q49166181-4E1E5429-3E56-4672-AB45-627448417845

P2860

Cellular therapies for treating pain associated with spinal cord injury

Item

http://www.wikidata.org/entity/Q35873511

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cellular therapies for treating pain associated with spinal cord injury

@ast

Cellular therapies for treating pain associated with spinal cord injury

@en

type

Item

label

Cellular therapies for treating pain associated with spinal cord injury

@ast

Cellular therapies for treating pain associated with spinal cord injury

@en

prefLabel

Cellular therapies for treating pain associated with spinal cord injury

@ast

Cellular therapies for treating pain associated with spinal cord injury

@en

P1476

Cellular therapies for treating pain associated with spinal cord injury

@en

P2093

Lawrence Leung

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

An endotoxin-induced serum factor that causes necrosis of tumors

Glial inhibition of CNS axon regeneration

The TNF and TNF receptor superfamilies: integrating mammalian biology

Regeneration beyond the glial scar

Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction

Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors

Mammalian G1 cyclins

Local and remote growth factor effects after primate spinal cord injury.

In vivo tracking of stem cells in brain and spinal cord injury.

Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines

P2888

1479-5876-10-37

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/1479-5876-10-37

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221681577

http://www.w3.org/2001/XMLSchema#string

P6179

1014654675

http://www.w3.org/2001/XMLSchema#string

P698

22394650

http://www.w3.org/2001/XMLSchema#string

P932

3320547

http://www.w3.org/2001/XMLSchema#string

Cellular therapies for treating pain associated with spinal cord injury

about

P2860

P2860

Cellular therapies for treating pain associated with spinal cord injury

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932